Office of the Director, National Institutes of Health; Notice of Meeting, 66249 [E8-26330]
Download as PDF
Federal Register / Vol. 73, No. 217 / Friday, November 7, 2008 / Notices
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: October 30, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–26435 Filed 11–6–08; 8:45 am]
Dated: October 30, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–26436 Filed 11–6–08; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
ebenthall on PROD1PC60 with NOTICES
Addiction Research Programs, National
Institutes of Health, HHS)
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Advisory Committee to the Director,
NIH.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Drug
Testing for Clinical Trials.
Date: December 2, 2008.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Courtyard by Marriott Rockville,
2500 Research Boulevard, Rockville, MD
20850.
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439, lf33c.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Non-Clinical ADME Studies.
Date: December 11, 2008.
Time: 9 a.m. to 6 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Courtyard by Marriott Rockville,
2500 Research Boulevard, Rockville, MD
20850.
Contact Person: Minna Liang, PhD,
Scientific Review Officer, Training and
Special Projects Review Branch, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, 6101 Executive Blvd.,
Room 220, MSC 8401, Bethesda, MD 20852,
301–435–1432, liangm@nida.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.279, Drug Abuse and
VerDate Aug<31>2005
15:04 Nov 06, 2008
Jkt 217001
Name of Committee: Advisory Committee
to the Director, NIH.
Date: December 5, 2008.
Time: 8:30 a.m. to 5 p.m.
Agenda: Among the topics proposed for
discussion are: (1) NIH Director’s Report; (2)
NIH Director’s Council of Public
Representatives Liaison Report; (3) Work
Group on Participant and Data Protection for
Gene-Wide Association Studies; and (4)
Report from NIH Blue Ribbon Panel on the
National Emerging Infectious Disease Lab at
Boston University Medical Center.
Place: National Institutes of Health,
Building 31, Conference Room 6, 9000
Rockville Pike, Bethesda, MD 20892.
Contact Person: Penny W. Burgoon, PhD,
Senior Assistant to the Deputy Director,
Office of the Director, National Institutes of
Health, 1 Center Drive, Building 1, Room
109, Bethesda, MD 20892, 301–451–5870,
burgoonp@od.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
66249
www.nih.gov/about/director/acd.htm, where
an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: October 28, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–26330 Filed 11–6–08; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
United States Immigration and
Customs Enforcement
Agency Information Collection
Activities: Extension of an Existing
Information Collection; Comment
Request
60-Day Notice of Information
Collection For Review; Secure
Communities IDENT/IAFIS
Interoperability State and Local Agency
Assessment; OMB Control No. 1653–
0040.
ACTION:
The Department of Homeland
Security, U.S. Immigration and Customs
Enforcement (USICE), will be submitted
the following information collection
request for review and clearance in
accordance with the Paperwork
Reduction Act of 1995. The information
collection is published to obtain
comments from the public and affected
agencies. Comments are encouraged and
will be accepted for sixty days until
January 6, 2009.
Written comments and suggestions
regarding items contained in this notice,
and especially with regard to the
estimated public burden and associated
response time should be directed to the
Department of Homeland Security
(DHS), Joseph M. Gerhart, Chief,
Records Management Branch, U.S.
Immigration and Customs Enforcement,
500 12th Street, SW., Room 3138,
Washington, DC 20024; (202) 732–6337.
Comments are encouraged and will be
accepted for sixty days until January 6,
2009. Written comments and
suggestions from the public and affected
agencies concerning the proposed
E:\FR\FM\07NON1.SGM
07NON1
Agencies
[Federal Register Volume 73, Number 217 (Friday, November 7, 2008)]
[Notices]
[Page 66249]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-26330]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the Advisory Committee to the Director, NIH.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Advisory Committee to the Director, NIH.
Date: December 5, 2008.
Time: 8:30 a.m. to 5 p.m.
Agenda: Among the topics proposed for discussion are: (1) NIH
Director's Report; (2) NIH Director's Council of Public
Representatives Liaison Report; (3) Work Group on Participant and
Data Protection for Gene-Wide Association Studies; and (4) Report
from NIH Blue Ribbon Panel on the National Emerging Infectious
Disease Lab at Boston University Medical Center.
Place: National Institutes of Health, Building 31, Conference
Room 6, 9000 Rockville Pike, Bethesda, MD 20892.
Contact Person: Penny W. Burgoon, PhD, Senior Assistant to the
Deputy Director, Office of the Director, National Institutes of
Health, 1 Center Drive, Building 1, Room 109, Bethesda, MD 20892,
301-451-5870, burgoonp@od.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: https://www.nih.gov/about/director/acd.htm, where an agenda and
any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: October 28, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-26330 Filed 11-6-08; 8:45 am]
BILLING CODE 4140-01-P